
Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
How are advances in point-of-care testing altering the genetic testing landscape, and what does this mean for the clinical lab?
The current landscape of molecular hematopathology—and what steps clinical labs can take to stay at the forefront of the discipline
The latest developments in liquid biopsy and ctDNA testing and why they should be of interest to clinical laboratory professionals
Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing